{"title":"A Bayesian adaptive design approach for stepped-wedge cluster randomized trials.","authors":"Jijia Wang, Jing Cao, Chul Ahn, Song Zhang","doi":"10.1177/17407745231221438","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Bayesian group sequential design has been applied widely in clinical studies, especially in Phase II and III studies. It allows early termination based on accumulating interim data. However, to date, there lacks development in its application to stepped-wedge cluster randomized trials, which are gaining popularity in pragmatic trials conducted by clinical and health care delivery researchers.</p><p><strong>Methods: </strong>We propose a Bayesian adaptive design approach for stepped-wedge cluster randomized trials, which makes adaptive decisions based on the predictive probability of declaring the intervention effective at the end of study given interim data. The Bayesian models and the algorithms for posterior inference and trial conduct are presented.</p><p><strong>Results: </strong>We present how to determine design parameters through extensive simulations to achieve desired operational characteristics. We further evaluate how various design factors, such as the number of steps, cluster size, random variability in cluster size, and correlation structures, impact trial properties, including power, type I error, and the probability of early stopping. An application example is presented.</p><p><strong>Conclusion: </strong>This study presents the incorporation of Bayesian adaptive strategies into stepped-wedge cluster randomized trials design. The proposed approach provides the flexibility to stop the trial early if substantial evidence of efficacy or futility is observed, improving the flexibility and efficiency of stepped-wedge cluster randomized trials.</p>","PeriodicalId":10685,"journal":{"name":"Clinical Trials","volume":" ","pages":"440-450"},"PeriodicalIF":2.2000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261240/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17407745231221438","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The Bayesian group sequential design has been applied widely in clinical studies, especially in Phase II and III studies. It allows early termination based on accumulating interim data. However, to date, there lacks development in its application to stepped-wedge cluster randomized trials, which are gaining popularity in pragmatic trials conducted by clinical and health care delivery researchers.
Methods: We propose a Bayesian adaptive design approach for stepped-wedge cluster randomized trials, which makes adaptive decisions based on the predictive probability of declaring the intervention effective at the end of study given interim data. The Bayesian models and the algorithms for posterior inference and trial conduct are presented.
Results: We present how to determine design parameters through extensive simulations to achieve desired operational characteristics. We further evaluate how various design factors, such as the number of steps, cluster size, random variability in cluster size, and correlation structures, impact trial properties, including power, type I error, and the probability of early stopping. An application example is presented.
Conclusion: This study presents the incorporation of Bayesian adaptive strategies into stepped-wedge cluster randomized trials design. The proposed approach provides the flexibility to stop the trial early if substantial evidence of efficacy or futility is observed, improving the flexibility and efficiency of stepped-wedge cluster randomized trials.
背景:贝叶斯分组序列设计已广泛应用于临床研究,尤其是 II 期和 III 期研究。它允许根据积累的中期数据提前终止研究。然而,迄今为止,贝叶斯分组序列设计在阶梯式分组随机试验中的应用还缺乏发展,而阶梯式分组随机试验在临床和医疗服务研究人员开展的实用性试验中越来越受欢迎:我们提出了一种针对阶梯式楔形分组随机试验的贝叶斯自适应设计方法,该方法可根据中期数据在研究结束时宣布干预有效的预测概率做出自适应决策。本文介绍了贝叶斯模型以及用于后验推断和试验进行的算法:我们介绍了如何通过大量模拟来确定设计参数,以实现所需的操作特性。我们进一步评估了各种设计因素(如步骤数、群组大小、群组大小的随机变异性和相关结构)如何影响试验属性,包括功率、I 类错误和早期停止的概率。本文介绍了一个应用实例:本研究介绍了将贝叶斯自适应策略纳入阶梯楔形分组随机试验设计的方法。所提出的方法提供了在观察到实质性疗效或无效证据时提前停止试验的灵活性,提高了阶梯楔形分组随机试验的灵活性和效率。
期刊介绍:
Clinical Trials is dedicated to advancing knowledge on the design and conduct of clinical trials related research methodologies. Covering the design, conduct, analysis, synthesis and evaluation of key methodologies, the journal remains on the cusp of the latest topics, including ethics, regulation and policy impact.